Biovail CEO challenged to TV debate; Mylan nabs Effexor approval

> The proxy fight between Biovail founder Eugene Melnyk and the company's management took a weird turn as the man Melnyk wants to head the company challenged its current CEO to a televised debate. Report

> Mylan Pharmaceuticals got the FDA's final nod for its copycat version of Effexor and plans to ship immediately; the company also got a tentative nod for its version of Sanofi Aventis' blood pressure med Avalide. Report

> Allergan received FDA approval for Trivaris, an injectable eye drug to treat retinal diseases. Report

> The Florida Medical Examiners Commission found that the rate of deaths caused by prescription drugs was three times the rate of deaths caused by all illicit drugs combined. Report

> Schering-Plough spent $520,000 in the first quarter to lobby on patent reform legislation, drug safety and other issues, according to a disclosure report. Report

> Medtronic got FDA approval to market its Starfix lead, a wire that delivers electrical pulses to the heart from a device that regulates heartbeat. Report

And Finally... How can doctors ensure patients take their medicine? Simple, give them a reward. Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.